This page, Information for providers about therapeutic treatments for COVID-19, is part of
This page, Information for providers about therapeutic treatments for COVID-19, is offered by

Information for providers about therapeutic treatments for COVID-19

About monoclonal antibody therapeutics for treatment of early mild-to-moderate COVID-19 in high-risk patients.

Table of Contents

Overview

The U.S. Food and Drug Administration (FDA) has issued emergency use authorizations (EUA) for three monoclonal antibody therapeutics for treatment of early mild-to-moderate COVID-19 in high-risk patients. Their names are:

Please note: Due to the presence of the Omicron variant and consistent with federal guidance, two monoclonal antibody (mAb) therapies, bamlanivimab/etesevimab and casirivimab/imdevimab, should no longer be used at this time.

Use of monoclonal antibodies or antiviral medications is not a substitute for vaccination against COVID-19. Everyone is still encouraged to get vaccinated as soon as they can, whether it is a first, second or booster dose.

In Massachusetts, DPH has contracted with Gothams to facilitate seven sites for monoclonal antibody therapy and oral antiviral therapies for high-risk patients who have been exposed to or have COVID-19. They are in Holyoke, Everett, Fall River, Lowell, Pittsfield, Athol, and Plymouth.

Please email or fax the Updated Provider Referral Form to the appropriate fax numbers below. All demographic and clinical information must be completed for the referral to be processed.

Everett

Fall River

Holyoke

 

Lowell

Pittsfield

Athol

  • Email: atholinfusion@gothams.com
  • Fax: 508-635-0132

Plymouth

Transportation to a treatment site should NOT be a barrier to care for patients diagnosed with COVID-19.  Gothams will work with your patient to arrange for transportation to and from the treatment site closest to their home.  There is no cost to the patient for this transportation.

Guidance

Monoclonal Antibody Therapy Locator

If you are having difficulty viewing the dashboard on a mobile or tablet device, you can link to the mobile view of the Monoclonal Antibody Therapy Locator.

Feedback